Intact SMAD-4 is a predictor of increased locoregional recurrence in upfront resected pancreas cancer receiving adjuvant therapy.
Gits HC, Tang AH, Harmsen WS, Bamlet WR, Graham RP, Petersen GM, Smyrk TC, Mahipal A, Kowalchuk RO, Ashman JB, Rule WG, Owen D, Neben Wittich MA, McWilliams RR, Halfdanarson T, Ma WW, Sio TT, Cleary SP, Truty MJ, Haddock MG, Hallemeier CL, Merrell KW.
Gits HC, et al.
J Gastrointest Oncol. 2021 Oct;12(5):2275-2286. doi: 10.21037/jgo-21-55.
J Gastrointest Oncol. 2021.
PMID: 34790392
Free PMC article.